The Biggest ADA 2026 Obesity Drug Breakthroughs ADA 2026 delivered a massive wave of obesity and diabetes data, and in this episode of On The Pen, Dave Knapp (@manonthemounjaro) sits down with Jen (@JcanNuSH) to break down the molecules, clinical trials, weight loss results, and safety signals that could define the next generation of obesity and diabetes medicine
Glp1 expression was detected in the midbrain and pons (interfascicular nucleus, ventral tegmental area, paranigral nucleus, and interpeduncular fossa), hippocampus (granular layer of the dentate gyrus), hypothalamus (posterior hypothalamic area and lateral hypothalamus), thalamus (dorsal lateral geniculate nucleus), and ependymal layer of the third ventricle
Seek professional guidance if side effects make the weekly schedule difficult
75% of GLP-1 users expressed that sexual health is as important as physical health in their weight-loss journey
Conclusion: The use of AID systems during a winter ski camp was found to be safe and glycaemia did not deteriorate
10.3892/ijmm.2018.3509 52 McIntyreN.HoldsworthC